Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,618.00
Bid: 1,582.00
Ask: 1,695.00
Change: 0.00 (0.00%)
Spread: 113.00 (7.143%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks rise as ECB pledges to speed up stimulus

Thu, 11th Mar 2021 17:00

(Alliance News) - Stocks in London ended higher on Thursday, amid a broad-based rally in European equities, as the European Central Bank committed to accelerating asset purchases.

The FTSE 100 index closed up 11.36 points, or 0.2%, at 6,736.96. The FTSE 250 ended up 126.43 points, or 0.6%, at 21,533.10. The AIM All-Share ended up 14.82 points, or 1.3%, at 1,197.52.

The Cboe UK 100 ended flat at 670.60, the Cboe UK 250 closed up 0.6%, at 19,142.33, the Cboe Small Companies ended 0.6% higher at 13,799.92.

In Paris the CAC 40 ended up 0.7%, while the DAX 30 in Frankfurt ended up 0.3%.

Spreadex analyst Connor Campbell said: "The ECB's promise to ramp up its bond buying program allowed the markets to maintain the week's positive glow on Thursday.

"It really has been a sharp turnaround from the bond yield-fearing, inflationary pressures-panicking losses that opened the month."

The euro stood at USD1.1960 at the European equities close, up from USD1.1900 late Wednesday in the wake of the European Central Bank's interest rate decision.

The Frankfurt-based central bank kept its interest rates on main refinancing operations, the marginal lending facility, and the deposit facility all unchanged at 0.00%, 0.25% and negative 0.50%, respectively. The ECB also left the size of its pandemic emergency purchase programme, or PEPP, unchanged at EUR1.85 trillion.

The ECB said after its latest monetary policy meeting that it will ramp up the pace of its pandemic emergency bond buys, in a bid to soothe market jitters about a rise in government borrowing costs and inflation.

While the ECB did not increase the overall amount of bond purchases planned, the announcement came as investor nervousness has already pushed up yields and despite the central bank acknowledging that inflation will likely run higher than expected in the short term.

"Rising yields are clearly a central issue given recent concerns, with the ECB taking action to drive down yields across the region. However, while the decision to front-load asset purchases under the PEPP scheme may have been designed to bring down yields, traders have seen right through it after initial declines were erased," said IG Group's Josh Mahony.

"Until the ECB decides to increase the overall size of the programme, today's decision to front-load PEPP purchases simply raises the chance of the scheme running its course earlier than expected. The clear correlation between yields and EURUSD meant we did see some initial weakness come into play after the announcement. However, just like the subsequent rise in yields, we are seeing EURUSD continue its recent rise later in the day," Mahony added.

On the London Stock Exchange, gambling firm Flutter Entertainment ended the best blue-chip performer, up 5.5% as it tracked shares in US peer DraftKings higher. Shares in Boston, Massachusetts-based DraftKings were up 3.3% in New York, having surged 9% on Wednesday following its investor day.

DraftKings said at its presentation to investors and analysts that it forecasts the total US online sports betting market represents a USD22 billion opportunity at 100% legalisation, which bodes well for the firm and main rival FanDuel - which is owned by Flutter.

Broker Davy, which reiterated its Outperform rating on Flutter, said: "Flutter Entertainment's current momentum confirms it is best positioned to capitalise on a wide-ranging set of global gaming opportunities. A clear leadership position in the US and fast-growing businesses in other key geographies are delivering strong top line progress."

At the other end of the large-caps HSBC ended the worst performer, down 4.7%, after the stock went ex-dividend, meaning new buyers no longer qualify for the latest payout. The Asia-focused bank also proposed to phase out all coal power financing by 2040 and affirmed its aim of committing up to USD1 trillion in green financing and investments.

Wm Morrison Supermarkets closed 1.8% lower after the grocer posted consensus-topping sales growth and profit, but noted it incurred GBP290 million in Covid-19-related costs.

In the financial year ended January 31, like-for-like sales growth, excluding both VAT and fuel, was up 8.6% annually. According to consensus compiled by Vuma, Morrisons was tipped to notch smaller like-for-like growth of 7.9%. In financial 2020, it posted a like-for-like sales fall of 0.8%, highlighting just how much the grocer's sales benefited from boosted demand amid Covid-19.

Annual revenue rose 0.4% to GBP17.60 billion from GBP17.54 billion. Pretax profit dropped 62% to GBP165 million from GBP435 million.

However, stripping out exceptional items, pretax profit beat forecasts. It came in at GBP201 million, down 51%, but marginally higher than the GBP200 million it was tipped to post, according to consensus.

Morrisons noted pretax profit before exceptional items would have been 5.6% higher year-on-year at GBP431 million, were it not for the GBP230 million of waived business relief rates it returned.

AstraZeneca closed down 2.5% after Danish health authorities suspended the use of the pharmaceutical group's Covid-19 vaccine as a precaution after some patients developed blood clots since receiving the jab. Norway later joined Denmark on putting the vaccine on hold.

Hikma Pharmaceuticals ended 1.9% lower after the generic drugmaker ended talks regarding the potential acquisition of GlaxoSmithKline's businesses in Egypt and Tunisia. GlaxoSmithKline closed down 0.6%.

In the FTSE 250, Marshalls closed up 8.2% after the concrete hard landscaping products maker said it made a strong start to 2021.

Marshalls reported a decline in 2020 revenue to GBP469.5 million from GBP541.8 million a year earlier, with pretax profit plummeting to GBP4.7 million from GBP69.9 million in 2019.

However, Marshalls said trading has started strongly in 2021, with sales at the end of February up 7% and orders up 12% compared to the same period in 2020.

At the other end of the midcaps, Helios Towers ended the worst performer, 6.0% lower. The telecom tower infrastructure company late Wednesday posted a rise in annual revenue against the backdrop of the global Covid-19 pandemic, but refrained from declaring a dividend.

The pound was quoted at USD1.3970 at the London equities close, up from USD1.3902 at the close Wednesday.

Against the yen, the dollar was trading at JPY108.51, down from JPY108.65 late Wednesday.

Stocks in New York were sharply higher at the London equities close as Congress passed US President Joe Biden's massive financial aid package and as jobs market improved.

The DJIA was up 0.9%, the S&P 500 index up 1.2% and the Nasdaq Composite up 2.1%.

US initial jobless claims decreased by 42,000 last week to 712,000 claims on the prior week's 754,000, both beating expectations and coming in at the lowest since November.

"The key takeaway from the initial jobless claims data is that initial claims are still high, but at least they are moving in a direction that suggests the economy is finding its growth stride again," said market analyst Patrick O'Hare at Briefing.com.

Brent oil quoted at USD69.32 a barrel at the equities close, up sharply from USD67.85 at the close Wednesday.

"Crude prices benefited from the broader risk-on rally and held onto gains after the monthly OPEC report showed a weaker demand outlook in the first half of the year due to Europe's restrictive measures to control COVID-19. Energy market traders are still expecting a tight oil market as OPEC+ will only raise output once the recovery in oil demand is clear," Oanda Markets analyst Edward Moya explained.

Gold was quoted at USD1,722.35 an ounce at the London equities close, slightly higher against USD1,719.15 late Wednesday.

The economic events calendar on Friday has the monthly UK GDP reading and industrial production data at 0700 GMT and US producer prices at 1330 GMT.

The UK corporate calendar on Friday has annual results from shopping centre operator Hammerson and a trading statement from housebuilder Berkeley Group.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more
11 Oct 2023 07:47

LONDON BRIEFING: Stocks lower; GSK settles Zantac case in California

(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.